Healthcare innovation is being reshaped by a critical challenge: organizations have more data than ever, yet much of it remains fragmented, difficult to access, and constrained by governance requirements. BC Platforms helps life sciences, healthcare, and research organizations turn that fragmentation into trusted evidence by combining governed data access, federated analytics, and AI-ready workflows within secure, scalable cloud environments. Through its collaboration with AWS, BC Platforms is extending this model to support faster, more responsible evidence generation at scale.
BC Platforms’ Role in Evidence Generation
BC Platforms is a global health technology company focused on making complex healthcare data usable for drug development, precision medicine, and evidence generation. Its solutions help life sciences and healthcare organizations connect clinical, genomic, imaging, and real-world data within secure digital environments, creating research-ready assets that can support decisions across the development lifecycle.
With more than 25 years of industry experience, BC Platforms supports organizations from discovery through clinical development and commercial decision-making. Its technology helps reduce the complexity of fragmented data, enable advanced cohort analysis, and accelerate insight generation. That role is becoming increasingly important as healthcare organizations seek secure, scalable ways to modernize research and generate evidence for precision medicine.
Federated Evidence Generation
As data, AI, and cloud computing converge, BC Platforms sees the industry moving beyond isolated technology adoption toward a new operating model for evidence generation. Valuable health data often remains distributed across hospitals, registries, biobanks, research networks, and life sciences organizations. BC Platforms’ federated model makes those assets usable while preserving governance, privacy, and local control.
That means bringing approved analytical tools, AI applications, and federated learning capabilities to governed data, rather than forcing sensitive data to move to the tools. Analyses can run across distributed environments while data remains under appropriate local control, strengthening privacy, sovereignty, collaboration, and responsible AI.
Solving the Fragmentation Barrier
Most healthcare systems were not designed to make distributed data usable across institutions, geographies, and modalities. Clinical, genomic, imaging, pathology, claims, and outcomes data often remain in separate systems, governed by different policies and mapped to different standards. That limits interoperability, slows evidence generation, and makes it harder to build representative datasets for precision medicine and real-world research.
BC Platforms addresses this challenge by starting with the evidence question and shaping the data network around it. Its distributed analytics model enables approved analysis across participating sites while custodians maintain responsibility for their data. The result is more representative evidence, less reliance on one-size-fits-all centralized repositories, and a practical path to scalable, compliant research.
BC Platforms supports this model through a combination of global data access, governed data networks, and enabling technology. At the center is its global data network, which provides access to patient-level data spanning more than 187 million patient lives across more than 35 countries. This reach helps customers move beyond generic data access to create bespoke, analysis-ready datasets and governed data networks tailored to specific evidence questions, populations, geographies, and therapeutic areas.
BC Platforms’ technology layer makes that network usable, secure, and scalable. BC Mosaic provides the trusted research environment for secure data access and collaboration; BC Image supports imaging data curation and analysis; and BC Catalyst serves as the AI-powered research intelligence layer, helping teams explore evidence opportunities, assess cohort feasibility, and prioritize the right data assets for precision medicine and real-world evidence generation. Underpinning these capabilities, BC Unify harmonizes, masters, and prepares fragmented healthcare data so it can be used confidently across the company’s solutions and customer-specific evidence-generation workflows.
AWS strengthens this model with cloud scale, compute flexibility, and broader deployment reach. Rather than presenting cloud as infrastructure alone, BC Platforms uses it as part of a governed evidence-generation architecture built for secure collaboration, advanced analytics, and AI-enabled research.
We’re not simply responding to the transformation; we’re helping define the secure, federated, and cloud-enabled evidence infrastructure that healthcare innovation increasingly requires.
Mukhtar Ahmed, CEO, BC Platforms
Governance That Accelerates Research
BC Platforms starts from a simple premise: healthcare data creates value only when it can be activated responsibly, securely, and at scale. Volume alone is not enough; data must be trusted, harmonized, well-governed, and fit for purpose. The company’s approach is anchored in four principles: data sovereignty, embedded governance, interoperability, and scalability.
In practice, this means data custodians retain control while access is permissioned, auditable, and secure. Approved analyses can run where the data resides, supporting collaboration across institutions and borders without compromising privacy, sovereignty, or regulatory obligations.
BC Platforms also addresses the foundational work that determines whether data can be used with confidence, including mastering, harmonization, semantic alignment, and rigorous quality processes. These capabilities transform complex clinical, genomic, imaging, and real-world datasets into trusted, analysis-ready assets. In this model, governance and innovation reinforce each other: strong controls create repeatable pathways for responsible research while enabling customers to generate evidence with greater speed, transparency, and regulatory integrity.
Building AI-Ready Healthcare Evidence Ecosystems
This governance foundation is what makes AI-ready healthcare ecosystems possible. Compute power alone is not enough; production-grade AI depends on secure data ingestion, multi-modal harmonization, scalable analytics, controlled access, clear provenance, and controls that can stand up to regulated use. AWS strengthens the infrastructure layer through scalable compute and cloud services, while BC Platforms brings healthcare-specific expertise in data mastering, trusted research environments, distributed analytics, compliance, and evidence generation. Together, these capabilities help customers move from AI experimentation to reliable, real-world workflows.
GPU-accelerated frameworks can streamline large-scale analytics, while federated learning supports model development across distributed environments without centralizing sensitive data. The critical requirement is not any single toolset, but a governed framework in which advanced methods can be deployed responsibly, with controls spanning access, auditability, data residency, provenance, and output review. That creates a flexible foundation for generative AI, federated learning, and digital twins while minimizing unnecessary data movement.
Turning Interoperability Into Evidence
Interoperability goes beyond connecting systems or aligning data standards. Its real value lies in making diverse datasets work together to generate meaningful insight. In precision medicine, this means connecting clinical, genomic, imaging, treatment, outcomes, and real-world data to create a more complete view of patients and populations. When those data assets can be understood and analyzed together, interoperability becomes a foundation for credible, scalable evidence generation.
This positions interoperability as an enabler of research and clinical innovation rather than a technical back-office function. Researchers, healthcare organizations, and life sciences companies can work across modalities, geographies, and governance frameworks while maintaining appropriate controls and avoiding unnecessary data movement.
The value also compounds over time. Cohort definitions, analytical methods, derived variables, and governance workflows can be reused across studies, turning previous research into institutional assets and accelerating future evidence generation. By making data more accessible, governed, and reusable, BC Platforms turns interoperability from a technical constraint into a strategic capability for precision medicine, collaborative research, and evidence-driven decision-making.
Strategic Scaling: Trusted Research with AWS
BC Platforms’ relationship with AWS extends beyond infrastructure to support faster deployment, product evolution, and scalable evidence generation. By optimizing BC Mosaic for AWS environments and making it available through AWS Marketplace, BC Platforms gives customers a more direct path from technology decision to deployment while expanding access to secure, cloud-enabled research infrastructure across healthcare, life sciences, and public-sector organizations.
The partnership also supports flexible research environments where approved tools, models, applications, and workflows can operate within governed spaces rather than requiring data to move into external systems. That flexibility is especially important as customers advance AI-enabled research while managing sovereignty, residency, compliance, and security requirements. Sovereign cloud deployment, including BC Mosaic on the AWS European Sovereign Cloud, helps customers combine cloud scale with jurisdictional control, operational autonomy, and regulatory assurance.
The future of healthcare AI depends on bringing approved tools to governed data, not forcing sensitive data to move to the tools.
Mukhtar Ahmed, CEO, BC Platforms
Making Compliance a Catalyst
BC Platforms views regulatory complexity as an opportunity to drive innovation when governance is embedded within the data infrastructure. Secondary data use, cross-border research, AI, real-world evidence, and public-private collaboration all require rigorous controls for consent, legal basis, permitted use, data residency, security, provenance, access, and analytical outputs.
By embedding those controls into repeatable workflows, organizations can move compliance out of the project-by-project checklist and into a scalable foundation for approved research. This also improves evidence quality by making data preparation, transformations, access histories, and analytical outputs more traceable and reviewable.
As frameworks such as the European Health Data Space (EHDS) continue to develop, secure environments for interoperable data discovery, access, reuse, and analysis will become more central to the operating model for healthcare research. Organizations that can demonstrate governed, interoperable, and federated data use across jurisdictions will be better equipped to collaborate internationally, generate trusted evidence, and strengthen relationships with data partners, regulators, and patients.
Enabling Trusted Collaboration
Healthcare innovation increasingly depends on collaboration among providers, researchers, pharmaceutical companies, and public institutions. Each group needs confidence that data can be accessed and analyzed securely, with clear permissions, auditability, local control, and transparency into how evidence is generated and reviewed. BC Platforms creates that confidence through a governance-led operating model supported by secure technology and cloud-enabled deployment options. Controlled research workspaces, role-based access, authentication, audit trails, project-specific permissions, and output controls help make collaboration safer and more transparent.
Federated architecture adds another layer of confidence because many data custodians cannot transfer patient-level data into a central repository. Approved analyses can run across participating environments while data remains under local control, and harmonized, well-documented data ensures the resulting evidence is comparable and reliable.
Outcome-Focused Innovation
BC Platforms takes an outcome-led approach to innovation, evaluating technology by the strategic decisions and measurable results it enables. In healthcare, innovation creates value when it helps researchers, clinicians, patients, and decision-makers act with greater speed, precision, and confidence. The work begins by defining the business or scientific objective.
Once the objective is established, BC Platforms aligns the underlying data, governance, analytics, and documentation framework to deliver it. Performance is assessed through tangible outcomes, including faster study initiation, shorter cohort discovery cycles, reduced duplication in data preparation, and greater reuse of analytical methods and cohort logic. Federated analytics further expands the potential impact by enabling evidence generation across broader populations and multiple sites without requiring datasets to be centralized.
For drug development and precision medicine, this approach enables access to representative, multi-modal evidence within a governed and traceable environment. BC Platforms measures innovation by the value it creates: enabling customers to reach evidence-based decisions faster, improve the quality of those decisions, and maintain confidence in the integrity, provenance, and reproducibility of the data, methods, and resulting insights.
Why Governed AI Depends on Multi-Modal Data?
Emerging technologies such as generative AI, multi-modal health data, federated learning, and digital twins are poised to reshape healthcare. BC Platforms believes the most profound shift will come from combining multi-modal health data with governed AI. These technologies depend on high-quality, representative, well-governed data foundations. Multi-modal data is especially powerful because disease biology and care delivery are not single-dimensional: understanding progression, treatment response, stratification, or outcomes requires connecting clinical data, genomics, imaging, pathology, laboratory data, treatments, and real-world context.
The next frontier is training and validating models across representative, governed, multi-modal datasets without forcing all data into one place. Federated learning and analytics will be critical because the data needed to train, validate, and apply models is distributed across institutions and countries, where centralization may not be permitted, fast, or sustainable.
For BC Platforms, this next chapter is about enabling AI to operate responsibly across trusted, scalable data ecosystems. With AWS supporting secure cloud scale and BC Platforms bringing governed data networks, healthcare-specific data expertise, and federated evidence-generation capabilities, organizations can connect representative multi-modal data, preserve governance and sovereignty, and generate insights that are actionable and defensible.
Building the Next Evidence Infrastructure
Our goal is to make trusted, data-driven healthcare innovation practical at global scale. That means helping organizations generate high-quality evidence from complex, distributed health data while maintaining security, governance, and sovereignty.
Mukhtar Ahmed, CEO, BC Platforms
BC Platforms’ next phase is focused on turning secure research environments into active evidence-generation platforms. That means advancing distributed analytics, hybrid data models, AI readiness, and bespoke data networks built around the questions customers need to answer.
This matters because the future of evidence generation will not be defined by access to more data alone. It will be defined by the ability to assemble the right data, from the right populations and geographies, within the right governance framework.
By aligning global data access, governance, analytics, and cloud-enabled collaboration around specific evidence questions, BC Platforms helps customers move from fragmented access to confident action.
In a future shaped by distributed data, governed AI, and cross-border collaboration, BC Platforms is building the evidence infrastructure that turns complex health data into trusted healthcare innovation at scale.
BC Platforms partners with NTT to accelerate data-driven medicine in Japan
BC Platforms and NTT join forces to integrate and harmonize Japanese healthcare data, supporting data-driven medicine and nationwide personalized care.
